View options
Result details

Results per page
Articles per page View Sort by

2 results matched your search query
Keywords = Prevalence

  • Open Access Research Article
    Export citation: APA   BibTeX   EndNote   RIS  
    Trends Journal of Sciences Research 2015, 2(4), 126-133. http://doi.org/10.31586/CardiovascularDisease.0204.03
    2 Views 23 Downloads 1 Citations PDF Full-text (882.186 KB)  HTML Full-text
    Abstract
    Cardiovascular disease (CVD) is a leading cause of further morbidity and mortality in type 2 diabetes patients. This study aimed to find the serum lipid profile, serum uric acid levels, other CVD risk factors, and how these factors are affected by diabetes duration in adults with type 2 diabetes. The
    [...] Read more.
    Cardiovascular disease (CVD) is a leading cause of further morbidity and mortality in type 2 diabetes patients. This study aimed to find the serum lipid profile, serum uric acid levels, other CVD risk factors, and how these factors are affected by diabetes duration in adults with type 2 diabetes. The cross- sectional study, involving 100 subjects, was carried out at the Diabetes Centre, Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana. Adult type 2 diabetes patients, 20 years or older, were recruited for the study. The National Cholesterol Education Program (NCEP) Adult Panel III and American Diabetes Association (ADA) guidelines were used to find the metabolic status of the patients. Of the 100 patients, 74% and 62% had high systolic blood pressure and abdominal obesity, respectively. Also, high LDL-cholesterol and hypercholesterolaemia were found in 47% and 46% of the patients, respectively. Forty-six percent (46%) of the patients were hyperuricaemic. Cardiovascular disease risk increased with age from 20 to 79 years. The female diabetics had more adverse CVD risk profile than the male diabetics (high LDL, 55% vs. 23.1%; high total cholesterol, 54.1% vs. 23.1%; high triglycerides, 32.4% vs. 30.8%; low HDL, 25.7% vs. 3.8%). Fifty percent (50%) of females compared to 34.6% of males were hyperuricaemic. However, hypertension was more prevalent among males (systolic blood pressure, 76.9%; diastolic blood pressure, 38.5%) than among females (systolic blood pressure, 73%; diastolic blood pressure, 37.8%). In conclusion, the prevalence of hyperuricaemia and other cardiometabolic risks was high among type 2 diabetes patients.  Full article
    References
    [1]
    Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007; 30:162-172
    [2]
    Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364:685-696
    [3]
    Adinortey MB, Gyan BE, Adjimani J, Nyarko P, Sarpong C, Tsikata FY et al. Dyslipidaemia associated with type 2 diabetics with micro and macrovascular complications among Ghanaians. Ind J Clin Biochem. 2011; 26(3):261-268
    [4]
    Danquah I, Bedu-Addo G, Terpe K, Micah F, Amoako YA, Awuku YA et al. Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health 2012; 12:210-217
    [5]
    Gibbons GF. Hyperlipidaemia of diabetes. Clin Sci. 1988;71:477-486
    [6]
    Haffner SM. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am J Cardiol. 2002; 90(8A):55i-61i
    [7]
    Mathura KC, Vaidya B, Gurbacharya DL. Study of serum lipid profile in type 2 diabetic patients attending KMCTH. Nepal Med Coll J. 2005; 7(2):97-100
    [8]
    Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J et al. Total cholesterol/HDL-cholesterol ratio versus LDL cholesterol/HDL cholesterol ratio as indices of ischaemic heart disease risk in men. The Quebec cardiovascular study. Arch Intern Med. 2001; 161: 2685-2692
    [9]
    Ryu KA, Kang HH, Kim SY, Yoo MK, Kim JS, Lee CH, Wie GA. Comparison of nutrient intake and diet quality between hyperuricemia subjects and controls in Korea. Clin Nutr Res. 2014; 3:56-63
    [10]
    Kim ES, Kwon HS, Ahn CW, Lim DJ, Shin JA, Lee SH et al. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications 2011; 25(5):309-313
    [11]
    Chien K, Chen M, Hsu H, Chang W, Su T, Lee Y, Hu FB. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem. 2008; 54(2):310-316
    [12]
    Mourad J. The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target. Vascular Health and Risk Management 2008; 4(6):1315-1325
    [13]
    Benetos A, Zureik M, Morcet J, Thomas F, Bean K, Safar M et al. Decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol. 2000; 35:673?680
    [14]
    Bays, HE, Chapman, RH, Grandy, S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidemia: comparison of data from two national surveys. Int J Clin Pract. 2007; 61 (5):737-747
    [15]
    Pasco JA, Nicholson GC, Brennan SLQ, Kotowic MA. Prevalence of obesity and the relationship between the body mass index and body fat: Cross-sectional, population-based data. PLoS ONE 2012; 7(1):e29580
    [16]
    Haffner SM, Stern MP, Hazuda HP, Pugh J, Patterson JK. Do upper body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non-insulin-dependent diabetes mellitus, lipids, and lipoproteins. Diabetes 1987; 36:43-51
    [17]
    Hou X, Lu J, Weng J, Ji L, Shan Z, Liu J. et al. Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: A national diabetes and metabolic disorders survey. PLoS ONE 2013; 8(3): e57319
    [18]
    Adamu MS, Owiredu WKBA, Plange-Rhule J. Metabolic syndrome in relation to body mass index and waist to hip ratio; a study in Kumasi Metropolis. J Obes Weight Loss Ther. 2014;4(1):211-219
    [19]
    Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract. 2002;56:197-205
    [20]
    Amoah AG. Sociodemographic variations in obesity among Ghanaian adults. Public Health Nutr. 2003;6:751-757
    [21]
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem. 1972;18:499-502
    [22]
    Shankar Prasad DS, Shruti P, Manjula R, Mamatha BV. Study of serum uric acid levels in type 2 diabetes mellitus without complications. Medica Innovatica 2013;2:72-76
    [23]
    World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. 1999 []
    [24]
    Adam IK, Sheye FA, Magami SM, Yusuf MB. Uric acid profile in apparently healthy people and diabetics. European Journal of Chemistry 2012;3(1):10?12
    [25]
    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-3421
    [26]
    American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2014; 37(1):S14-S80
    [27]
    Jha N. A comparative study of coronary and contributory risk factors in rural and urban type 2 diabetics. Kathmandu Univ Med J. 2004;2(1):28-34
    [28]
    Kamath A, Shivaprakash G, Adhikari P. Body mass index and waist circumference in type 2 diabetes mellitus patients attending a diabetes clinic. Int J Biol Med Res. 2011;2(3):636-638
    [29]
    Awa WL, Fach E, Krakow D, Welp R, Kunder J, Voll A et al. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120 183 patients from the German/Austrian DPV database. European Journal of Endocrinology 2012;167:245?254
    [30]
    Gautier A, Roussel R, Ducluzeau PH, Lange C, Vol S, Balkau B et al. Increases in waist circumference and weight as predictors of type 2 diabetes in individuals with impaired fasting glucose: influence of baseline BMI data from the DESIR study. Diabetes Care 2010;33:1850?1852
    [31]
    Meigs JB, Wilson PW, Nathan DM, D?Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160-2167
    [32]
    Hu J, Wallace DC, Jones E, Liu H. Cardiometabolic health of Chinese older adults with diabetes living in Beijing, China. Public Health Nursing 2009;26 (6):500-511
    [33]
    Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetology & Metabolic Syndrome 2010;2:1-5
    [34]
    Al-mukhtar SB, Fadhil NN, Hanna BE. Serum lipid profile in subjects with type 2 diabetes mellitus and hypertension in relation to metabolic syndrome: a case control study. Duhok Med J. 2012;6(2):29-44
    [35]
    Wang J, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005;45:907-913
    [36]
    Codario RA. Risk reduction in diabetic patient. In: Skolink NS, editor. Type 2 Diabetes, Pre-diabetes, and the Metabolic Syndrome. 2nd ed. Humana Press, Springer. New York; 2011. p. 297
    [37]
    Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in native African type-2 diabetic patients. J Natl Med Assoc. 2005;97:557-563
    [38]
    Wang J, Chen R, Lei L, Song Q, Zhang R, Li Y et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China. Asia Pac J Clin Nutr. 2013;22(4):590- 598
    [39]
    Pathak, R, Pathak A. Study of lifestyle habits on risk of type 2 diabetics. Int. J App Basic Med Res. 2012;2: 92-96
    [40]
    Ogbera AO, Fasanmade OA, Chinenye S, Akinlade A. Characterization of lipid parameters in diabetes mellitus - a Nigerian report. International Archives of Medicine 2009;2:19-25
    [41]
    Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332(7533):73-78
    [42]
    Juutilainen A, Kortelainen S, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 27:2898-2904
    [43]
    Canoy D, Cairns BJ, Balkwill A, Wright FL, Green J, Reeves G, Beral V. Body mass index and incident coronary heart disease in women: a population-based prospective study. BMC Medicine 2013;11:87-96
    [44]
    Hernandez-Ono A, Monter-Carreola G, Zanora-Gonzalez J, Cardoso-Saldana G, Posadas-Sanchez R, Torres-Tamayo M, Posadas-Romero C. Association of visceral fat with coronary risk factors in a population-based sample of postmenopausal women. Int J Obes Relat Metab Disord. 2002;26(1):33-39
  • Open Access Research Article
    Export citation: APA   BibTeX   EndNote   RIS  
    Trends Journal of Sciences Research 2019, 4(2), 80-87. http://doi.org/10.31586/InfectiousDiseases.0402.05
    24 Views 6 Downloads PDF Full-text (700.008 KB)  HTML Full-text
    Abstract
    Background: Anemia is the most frequent hematologic abnormality of HIV disease and one of the most common manifestations of nutritional deficiency disorders in the world. In sub-Saharan Africa, about 70% of the world’s people living with HIV/AIDS, where the prevalence of anemia is higher than in developed countries. The aim
    [...] Read more.
    Background: Anemia is the most frequent hematologic abnormality of HIV disease and one of the most common manifestations of nutritional deficiency disorders in the world. In sub-Saharan Africa, about 70% of the world’s people living with HIV/AIDS, where the prevalence of anemia is higher than in developed countries. The aim of this study was to determine the prevalence and factors associated with anemia among people living with HIV at Dodoma regional hospital during 2013-2014. Methodology: A retrospective cross-section study conducted among PLWHIV at Dodoma Regional Hospital between 2015 and 2016. A total of 869 PLWHIV were enrolled. Data extraction sheet were used to collect Socio- demographics, immune-hematological data and ARV status from existing patient’s files (CTC 2 card). Double entry of data in Microsoft excel were done and transferred for analyzing using SPSS v.16. Results: Majority of them were females 648(74.6%)and 508(58.2%) were between 19-45years with mean age of 38.84(±14.09). 824(94. 8%) were on ARV; where 640(73.6%) are from urban. The overall prevalence of anaemia among PLHIV was 59.5% of which 56.6% of these were on ARV, and 2.9% were not on ARV. Age, sex and CD4+ counts < 200cell/µl were among factors associated with anemia among PLWHIV. Conclusion: Moderate anaemia was common in the study population. Screening and management of anemia along with the proper use Anti-retroviral therapy may decrease risk of anemia and the effect ARV on red blood cells. Haemoglobin measurements should be taken before initiation of ARV and routinely followed among ARV users.  Full article
    Figures

    Figure 2 of 2

    References
    [1]
    Tesfaye Z and Enawgaw B (2014) Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia : a retrospective study. 7(1): 1-5.
    [2]
    Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, Gundersen SG and Bruun JN (2008) Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. 10: 1-10.
    [3]
    Alem M, Kena T, Baye N, Ahmed R and Tilahun S (2013) Patients at the Anti-Retroviral Therapy Clinic at the University of Gondar. 2(3).
    [4]
    Ferede G and Wondimeneh Y (2013) Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital , Northwest Ethiopia. BMC Blood Disorders. BMC Blood Disorders 13(1): 1. Available at: BMC Blood Disorders.
    [5]
    Santiago-rodríguez EJ, Mayor AM, Fernández-santos DM, Ruiz-candelaria Y and Hunter-mellado RF (2014) Anemia in a cohort of HIV-infected Hispanics : prevalence , associated factors and impact on one-year mortality. 1-8.
    [6]
    Martin C, Poudel-tandukar K and Poudel KC (2014) HIV Symptom Burden and Anemia among HIV-Positive Individuals : Cross-Sectional Results of a Community-Based Positive Living with HIV ( POLH ) Study in Nepal. 1-16.
    [7]
    Brien MEO, Kupka R, Msamanga GI, Saathoff E, Hunter DJ and Fawzi WW (2005) Anemia Is an Independent Predictor of Mortality and Immunologic Progression of Disease Among Women With HIV in Tanzania. 40(2): 219-225.
    [8]
    Belperio PS and Rhew DC (2004) Prevalence and Outcomes of Anemia in Individuals with Human Immunodeficiency Virus : A Systematic Review of the Literature. 27-43.
    [9]
    Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M and Working HI V (2004) Anemia in HIV Infection : Clinical Impact and Evidence-Based Management Strategies. 94121.
    [10]
    Mata-marín JA, Gaytán-martínez JE, Martínez-martínez RE, Arroyo-anduiza CI, Fuentes-allen JL and Casarrubias-ramirez M (2010) Risk factors and correlates for anemia in HIV treatment-naïve infected patients : a cross-sectional analytical study. 3–7.
    [11]
    Cunha G, Santis D, Menezes D, Crivelenti F, Branda RA, Zomer R, Muniz DA, Momo G, Lima N De, Amorelli-chacel ME, Tadeu D and Artioli A (2011) International Journal of Infectious Diseases Hematological abnormalities in HIV-infected patients. 15: 808-811.
    [12]
    Zhou J, Jaquet A, Bissagnene E, Musick B, Wools-kaloustian K, Maxwell N, Boulle A, Wehbe F, Masys D, Iriondo-perez J, Hemingway-foday J and Law M (2012) Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV- infected patients in countries in sub-Saharan Africa , Asia-Pacific , and central and South America. Journal of the International AIDS Society. BioMed Central Ltd 15(1): 5. Available at: http://www.jiasociety.org/content/15/1/5.
    [13]
    Shen Y, Wang Z, Lu H, Wang J, Chen J, Liu L and Zhang R (2013) Prevalence of Anemia among Adults with Newly Diagnosed HIV / AIDS in China. 8(9): 1-6.
    [14]
    Amitis Ramezani, Arezoo Aghakhani, Mohammad Reza Sharif, Mohammad Banifazl, Ali Eslamifar, Ali Akbar Velayati (2008). Anemia Prevalence And Related Factors In HIV-Infected Patients: A Cohort Study. Iranian Journal of Pathology. 3(3), 125-128.
    [15]
    Agarwal D, Chakravarty J, Chaube L, Rai M, Agrawal NR and Sundar S (2010) High incidence of zidovudine induced anaemia in HIV infected patients in eastern India. (October): 386-389.
    [16]
    Omoregie R, Omokaro EU, Palmer O, Ogefere HO and Egbeobauwaye A (2009) Prevalence of anaemia among HIV-infected patients in Benin City, Nigeria. 11(1).
    [17]
    Lealem G, Tilehum Y, Zewdineh S, Daniel Y (2013). Anemia and Risk Factors in HAART Naıve and HAART Experienced HIV Positive Persons in South West Ethiopia: A Comparative Study. PLOS ONE. 8:8 | e72202.
    [18]
    Johannessen A, Naman E, Gundersen SG and Bruun JN (2011) Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infectious Diseases. BioMed Central Ltd 11(1): 190. Available at: http://www.biomedcentral.com/1471-2334/11/190.
    [19]
    Denue BA, Bello HS and Abja AU (2013) Changes in blood profile of human immunodeficiency virus ( HIV ) -infected patients on highly active antiretroviral therapy ( HAART ) in North Eastern Nigeria. 5(8): 284-291.
    [20]
    Obirikorang C and Yeboah FA (2009) Blood haemoglobin measurement as a predictive indicator for the progression of HIV / AIDS in resource-limited setting. 7: 1–7.
    [21]
    Curkendall SM, Richardson JT, Emons MF, Fisher AE and Everhard F (2007) Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy *. 483-490.
    [22]
    Mugisha JO, Shafer LA, Paal L Van Der, Mayanja BN, Eotu H, Hughes P, Whitworth JAG and Grosskurth H (2008) Anaemia in a rural Ugandan HIV cohort : prevalence at enrolment , incidence , diagnosis and associated factors. 13(6): 788–794.
Filter options
Publication Date
From to
Refine Publication Date
Subject Areas
Refine Subjects
Article Types
Refine Article Types
Countries / Territories
Refine Countries / Territories